Predictive Risk Intelligence | Chest X-ray First

Turn routine chest X-rays into 1 to 3 year lung cancer risk insights.

PneuScan AI is a clinical decision support tool that estimates near-term lung cancer risk from everyday chest X-rays. It helps healthcare teams prioritize follow-up screening with minimal workflow disruption.

Made for scale Designed to run on high-volume imaging workflows
Trust focused Risk band, explainability overlay, and report summary

Interactive preview

Risk Stratification Output

Estimated risk band Moderate
42%

Moderate risk suggests closer follow-up based on clinical criteria.

  • Risk band plus probability range
  • Explainability overlay for clinician review
  • Suggested follow-up pathway

Disclaimer: This is a demo UI. PneuScan AI supports clinical decision-making and does not diagnose disease.

What we do

PneuScan AI adds predictive risk intelligence to routine chest X-rays so health systems can identify elevated-risk patients earlier and prioritize screening resources more effectively.

Risk stratification

Estimates near-term risk to support screening decisions and care pathways.

Opportunistic screening

Uses X-rays already taken daily for checkups, clearances, and urgent care workflows.

Workflow ready output

Generates a clean report summary designed for clinical review and pilot deployment.

Key features

Built for real adoption with clear outputs, quality handling, and workflow-ready reporting.

Core Output

Short-term risk band

Converts routine chest X-rays into a 1 to 3 year risk band with a probability range to support decision-making.

  • Low, Moderate, Elevated categories
  • Probability range for context
  • Next-step suggestion for screening
Trust Layer

Explainability overlay

Provides an interpretable overlay highlighting regions that influenced the model score for clinical review.

  • Visual contribution map
  • Report rationale summary
  • Audit-friendly traceability
Deployment

Workflow-ready report

Outputs a clean one-page report designed to fit clinical workflows and enable validation pilots.

  • Clear risk statement
  • Follow-up guidance language
  • Professional format

Quality-aware preprocessing

Standardizes noisy real-world X-rays to reduce variability across different machines and settings.

  • Normalization and contrast standardization
  • Lung region focus to reduce distractions
  • Quality flags for low-quality inputs

Clinical safety and governance

Designed as decision support with guardrails and traceability to support responsible deployment.

  • Risk stratification only, not diagnosis
  • Model version and timestamp support
  • Validation and audit readiness

High-volume readiness

Built for settings where imaging volume is high and staff time is limited.

  • Fast inference design approach
  • Report output to reduce extra steps
  • Deployment-friendly architecture

Roadmap: CT refinement module

When CT is available, PneuScan can refine risk and support follow-up monitoring for flagged patients.

  • CT refinement for higher resolution review
  • Follow-up comparison over time
  • Stronger clinical decision support
0
Primary modality for Phase 1
0
Risk horizon target in years
0
Extra scans required for scoring

How it works

Click a step to focus it. This is designed for simple clinical deployment workflows.

Important: PneuScan AI supports decision-making and does not replace clinical judgment.

Built for trust

Medical AI must be responsible, transparent, and designed for clinical adoption.

Responsible outputs

Risk-focused reporting designed to support appropriate follow-up decisions.

Explainability first

Clinicians can review what contributed to the estimate and interpret results more confidently.

Validation pathway

Designed for retrospective validation, external testing, and pilot studies in real settings.

About Us

We are third-year BS Computer Science students building PneuScan AI, a predictive risk intelligence tool that analyzes chest X-rays and estimates the likelihood of lung cancer risk within 1 to 3 years. Our goal is to support earlier screening decisions by turning routine imaging into actionable, clinician-friendly insights.

Our mission

Help healthcare teams identify elevated-risk patients earlier, prioritize follow-up screening, and reduce late-stage lung cancer outcomes through accessible and workflow-ready AI.

Chest X-ray first 1 to 3 year risk horizon Decision support
Jaymar H. Maruji

Jaymar H. Maruji

Founder and Product Lead

Focused on building a practical medical AI product that fits real clinical workflows, prioritizes trust, and delivers measurable impact.

  • Vision and roadmap
  • Model direction and validation planning
  • Product and clinical workflow design
Bradnil S. Tumalon

Bradnil S. Tumalon

Lead Developer and Engineering

Builds the platform foundation for secure uploads, model inference flow, and a clean UI that communicates results clearly.

  • Web experience and UI engineering
  • Model integration and deployment
  • Data pipeline and system reliability

Request a clinical demo

Get a pilot-ready walkthrough of the risk report experience, integration approach, and validation roadmap.

We will reply with a demo deck and pilot discussion steps.